series-c-plus
Stage
1
Investors
About
Celea Therapeutics develops treatments for liver diseases, focusing on addressing fibrotic and metabolic liver conditions.
Explore Celea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.